South Korea is the plastic surgery capital of the world. These companies are manufacturing botox strains - but the big business is abroad, if they can crack the China and U.S. markets.
Lower your exposure to equities here and completely discard stocks of companies that are not earning their cost of capital.
A railway operator and a developer indicate corporate governance finally may be shifting in the favor of shareholders in Japan, with nice upside potential for the stocks as a result.
With Japan's stock market having doubled under Prime Minister Shinzo Abe, will a new emperor see the progress continue?
Negative political pressure is being felt in an overbearing way on the entire healthcare sector.
President Trump's decision to pull out of the Trans-Pacific Partnership has left the U.S. in a weaker trade position with Japan and other partnership members.
Fashion may be a fickle beast for stock prices, but solid, high-yielding dividend coverage is a buy every time.
The Japanese people are looking forward with optimism to the Reiwa age.
These high-flying Japanese companies will likely get a boost come August with the rebalancing of a key stock index.
The qualitative selection of stocks in the JPX-Nikkei Index 400 sets it apart from the Nikkei 225.